News & Press Releases Press ReleasePress Release for Expansion of Manufacturing Capacity of API Albendazole to meet Global Demand Pressrelease - Resumes Operations in All Units Situated in Mahad and ChiplunTranscript Earnings CallCon call Invitation - Q1 FY 2022Analyst Call intimation Q3FY21Press Release LASA WHO GMPPressRelease (Court Order)Lasa Q2 FY21 Press ReleaseIPR Interim CoverageLasa Supergenerics Brokerage Report September 2020Lasa Supergenerics Brokerage Report August 2020Lasa Supergenerics jumps 5% on acquiring a firmBS Eng Newspaper adPress Release Acquisition HarishreeBS Hin Newspaper AdMoneytimes_27.01.2018Navshakti newspaper adFree Press Newspaper adMoneytimes_01.01.2018Lasa Media Coverage ReportBusiness StandardLasa Supergenerics lists at Rs 140.20 on NSE; Omkar Speciality drops 5% - The Economic TimesReutersLasa Supergenerics breaches upper circuit, Omkar Speciality down - India InfolineHindu Business Line Press Release withdrawal of Application under Section 7 filed against the company by BOB
